Riskpilot← Back to searchSign inGet full accessSYNAPSEKLINIKKEN AS
ASActiveOrg 933812839Sørkedalsveien 10, 0369 OsloMedical specialists activities · NACE 8622Est. 2024— employees
Revenue 2024
NOK 178K
EBITDA margin
-88.7%
Equity ratio
31.8%
Financial strength
Net profit 2024
NOK -158K
| Revenue | NOK 178K | — |
| EBITDA | NOK -158K | — |
| Net profit | NOK -158K | — |
| Total assets | NOK 133K | — |
| Equity | NOK 42K | — |
| Employees | — | — |
Legal name
SYNAPSEKLINIKKEN AS
Org number
933812839
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
19. juli 2024
Share capital
NOK 200 000
Employees
—
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder eller styrets leder hver for seg.
Company purpose
Helsetjenester, forskning og faglig utvikling, samt hva dermed står i forbindelse, herunder å forvalte verdier til beste for virksomheten.
Address
Sørkedalsveien 10, 0369 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2024 |
|---|---|
| Revenue | 178 |
| Staff expenses | −0 |
| EBITDA | −158 |
| Depreciation & amort. | −0 |
| EBIT | −158 |
| Net financials | 0 |
| Profit before tax | −158 |
| Tax | −0 |
| Net profit | −158 |
| Item | 2024 |
|---|---|
| Total assets | 133 |
| Equity | 42 |
| Long-term debt | 0 |
| Short-term debt | 91 |
| Total debt | 91 |
EBITDA margin
-88.7%
This company
15.8%
Market median
-661% vs market
20242024
Equity ratio
31.8%
This company
38.2%
Market median
+17% vs market
20242024
Return on equity
-372.2%
This company
18.4%
Market median
-2123% vs market
20242024
Net profit margin
-88.7%
This company
8.1%
Market median
-1195% vs market
20242024
Asset turnover
1.33×
This company
1.12×
Market median
+19% vs market
20242024
Debt / equity
2.15×
This company
0.62×
Market median
-247% vs market
20242024
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
WS Chief Executive Officer | Chief Executive Officer | 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Board of Directors | 2024 | |
| Chairman | 2024 | |
| Board of Directors | 2025 | |
| Chairman | 2025 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 24% | 24% | 2024 | |
| Company | 24% | 24% | 2024 | |
| Company | 18% | 18% | 2024 | |
| Individual | 14% | 14% | 2024 | |
| Individual | 10% | 10% | 2024 | |
| Individual | 10% | 10% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of SYNAPSEKLINIKKEN AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Wenche Sabel | Chief Executive Officer | 0 companies |
| Mads Alexander Sabel | Board of Directors | 0 companies |
| Tore Hind Fagerlund | Chairman | 0 companies |
| Tore Bergfjord | Board of Directors | 0 companies |
| Kine Winther Sabel | Chairman | 0 companies |